阿根廷研究员为糖尿病患者开发新型 3D 生物打印伤口敷料

2018-02-05 佚名 天工社

糖尿病患者往往特别容易受到皮肤伤口引起的细菌感染的影响。近日,阿根廷的一组研究员利用 3D 打印技术设计了一系列可定制的的伤口敷料,大大改善了伤口愈合的过程,防止了危险感染的传播。

糖尿病患者往往特别容易受到皮肤伤口引起的细菌感染的影响。近日,阿根廷的一组研究员利用 3D 打印技术设计了一系列可定制的的伤口敷料,大大改善了伤口愈合的过程,防止了危险感染的传播

这项开创性的新项目是由阿根廷国家科学和技术研究委员会 CONICET 和工业发酵研究与发展中心(CINDEFI)纳米生物材料实验室的团队合作进行的,他们之前已经研究过几款创新性的 3D 生物打印系统,其中包括一款能够以独特的方式组合聚合物的双注射器 3D 打印机。


以腿部和脚部创伤为重点开始,研究团队利用 3D 扫描对受影响的皮肤区域进行扫描,然后 3D 打印伤口敷料的设计,以便完美地贴合患者的皮肤,从而优化其烧灼能力。敷料将加入一种抗生素,以对抗可能在坏死组织周围生长的细菌感染。

据高级研究员吉列尔莫·卡斯特罗(Guillermo R. Castro)表示,定制的打印敷料可以呈现其特征,根据损伤的形状和深度定制治疗方法、抗生素和服用剂量,记住许多人对某些药物的不良反应。


3D 生物打印工艺采用了一种特殊的生物基凝胶材料。这种大分子生物聚合物促进修复皮肤伤口所需细胞的生长,并且容易建模成所需形状和图案以适应伤口,并有效管理抗生素。为了开发这种处理方法,从头设计了一个新的打印系统,每个伤口敷料的总打印时间不应超过半小时。如果这项技术成功地证明了这一点,那么它很快就可以应用到身体不同部位更大范围的伤口上。不仅如此,还可以用来治疗烧伤引起的病变。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-12-19 zhmscau
  2. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-09-28 guozhenyu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1988509, encodeId=9f8a198850938, content=<a href='/topic/show?id=1637e3378a8' target=_blank style='color:#2F92EE;'>#研究员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73378, encryptionId=1637e3378a8, topicName=研究员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Wed Dec 19 08:54:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634631, encodeId=0d661634631a4, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Fri Sep 28 22:54:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818546, encodeId=56a9181854640, content=<a href='/topic/show?id=5fda9e85177' target=_blank style='color:#2F92EE;'>#阿根廷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97851, encryptionId=5fda9e85177, topicName=阿根廷)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3ad2500191, createdName=12498dd9m11暂无昵称, createdTime=Sat Jun 02 14:54:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336030, encodeId=2a571336030a0, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474426, encodeId=2ed014e44265b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Feb 07 02:54:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=285363, encodeId=9b282853638d, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Mon Feb 05 13:23:46 CST 2018, time=2018-02-05, status=1, ipAttribution=)]
    2018-02-05 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关资讯

Eur Heart J:高心血管风险的糖尿病患者血压和心血管结局分析!

由此可见,对于心血管疾病风险升高的糖尿病患者,即使在对潜在疾病负担进行了广泛调整后,较低的舒张压与亚临床心肌损伤和心肌梗死风险之间仍然存在着持续的联系。

J Clin Periodontol:牙周炎和糖尿病相关的致病机制的研究

Taylor(Journal of Clinical Periodontology,2013,40,S113)关于牙周炎与糖尿病之间生物学关联的科学证据的更新。

中国2型糖尿病自我管理处方专家共识 (2017年版)

流行病学调查显示,我国成年人2型糖尿病患病率为9.7%~11.6%,已成为全球糖尿病患者最多的国家。糖尿病作为慢性终身性疾病,患者生活质量的提高有赖于自身管理[3,4]。有效的糖尿病自我管理教育和支持(diabetes self-management education/support,DSME/S)是协助糖尿病患者管理和维持自身健康行为的基础。我国的糖尿病教育管理起步于20世纪90年代中期,最初

J Gen Intern Med:哪些糖尿病患者更容易被过度治疗?

2018年1月,发表在《J Gen Intern Med》的一项由美国科学家进行的研究,考察了Medicare医保人群中糖尿病过度治疗与去强化(宽松)治疗。

JCEM:血浆caspase-8浓度与睡眠时间短以及糖尿病风险有关!

由此可见,睡眠时间与血浆caspase-8相关。血浆caspase-8可以独立预测糖尿病发病,并改变睡眠时间对糖尿病发生的影响。未来的研究应探讨睡眠时间变化是否会影响血浆中caspase-8的浓度。

糖尿病随着时间的发展是如何变化的,如何管理血糖才能趋向正常

糖尿病是一种慢性疾病,据统计,全球受到糖尿病伤害的人数正在不断攀升,预计到2050年,这一数字将会达到顶峰。